Subsequently, the same group demonstrated that the follicle-stimulating hormone (FSH) increased both LEDGF/p75 and VEGF-C expression in ovarian carcinoma cells, and augmented LEDGF/p75 binding to STRE in the VEGF-C promoter region [42]. Here, PSIP1 is linked to ovarian carcinoma.